Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The GLP-1 Bridge Program is a short-term demonstration project that, for the first time, gives Medicare beneficiaries with Part D coverage access to GLP-1 drugs, prescribed for weight loss
Over time, the reduction in melanin production leads to lighter skin with fewer dark spots and uneven pigmentation
Trace Curry with JourneyLite Physicians
Wegovy is HSA eligible when prescribed for a qualifying diagnosis
Doctors can prescribe several other options
According to Belle Health safety information, these medications are contraindicated for individuals with: Personal or family history of medullary thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 (MEN2) History of pancreatitis Known hypersensitivity to tirzepatide or any of its components Additionally, women who are pregnant, planning to become pregnant, or breastfeeding should not use tirzepatide
